Cover Image

Preclinical Evaluation of the Multiple Tyrosine Kinases Inhibitor Anlotinib in Leukemia Stem Cells

Leukemia stem cells (LSCs) constitute the critical barrier to the cure of acute myeloid leukemia (AML) due to their chemoresistance and immune evasion property. Herein, the role of anlotinib, a multiple tyrosine kinase inhibitor, in killing LSCs and regulating chemoresistance and immune evasion was...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuelong Jiang (Author), Long Liu (Author), Yirong Jiang (Author), Zhifeng Li (Author), Liying Feng (Author), Xinguo Zhuang (Author), Zhijuan Lin (Author), Qiuling Chen (Author), Guoshu Chen (Author), Jixiang He (Author), Guowei Li (Author), Jie Zha (Author), Bing Xu (Author)
Format: Book
Published: MDPI AG, 2022-10-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items